Tumor-mediated shape-transformable nanogels with pH/redox/enzymatic-sensitivity for anticancer therapy
نویسندگان
چکیده
منابع مشابه
PP2A-Mediated Anticancer Therapy
PP2A is a family of mammalian serine/threonine phosphatases that is involved in the control of many cellular functions including protein synthesis, cellular signaling, cell cycle determination, apoptosis, metabolism, and stress responses through the negative regulation of signaling pathways initiated by protein kinases. Rapid progress is being made in the understanding of PP2A complex and its f...
متن کاملExploiting tumor cell senescence in anticancer therapy
Cellular senescence is a physiological process of irreversible cell-cycle arrest that contributes to various physiological and pathological processes of aging. Whereas replicative senescence is associated with telomere attrition after repeated cell division, stress-induced premature senescence occurs in response to aberrant oncogenic signaling, oxidative stress, and DNA damage which is independ...
متن کاملSecond order sensitivity analysis for shape optimization of continuum structures
This study focuses on the optimization of the plane structure. Sequential quadratic programming (SQP) will be utilized, which is one of the most efficient methods for solving nonlinearly constrained optimization problems. A new formulation for the second order sensitivity analysis of the two-dimensional finite element will be developed. All the second order required derivatives will be calculat...
متن کاملAnticancer drug sensitivity by human tumor clonogenic assay.
The anticancer drug sensitivity of human cancers was tested by the human tumor clonogenic assay (HTCA). Of 152 human cancer specimens tested, 63 (41%) formed more than 30 tumor cell colonies in control plates and could be used to evaluate the drug sensitivity of tumor cells. In 42 (93%) of 45 clinical trials in 24 patients, a parallel correlation was observed between the in vitro anticancer dru...
متن کاملApoptosis, p53, and tumor cell sensitivity to anticancer agents.
A widely held tenet of present day oncology is that tumor cells treated with anticancer agents die from apoptosis, and that cells resistant to apoptosis are resistant to cancer treatment. We suggest, in this review, that this tenet may need to be reexamined for human tumors of nonhematological origin, for two principal reasons: (a) cell killing has often been assessed in short term assays that ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Materials Chemistry B
سال: 2020
ISSN: 2050-750X,2050-7518
DOI: 10.1039/d0tb00143k